nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A model of interaction: Aflatoxins and hepatitis viruses in liver cancer aetiology and prevention
|
Wild, Christopher P. |
|
2009 |
286 |
1 |
p. 22-28 7 p. |
artikel |
2 |
A national collection of liver tumours: Lessons learnt from 6 years of biobanking in France
|
Clément, Bruno |
|
2009 |
286 |
1 |
p. 140-144 5 p. |
artikel |
3 |
Cancer letters special issue hepatocellular carcinoma featuring the guest editors
|
|
|
2009 |
286 |
1 |
p. 1-2 2 p. |
artikel |
4 |
Comparative analysis of the liver and plasma proteomes as a novel and powerful strategy for hepatocellular carcinoma biomarker discovery
|
Beretta, Laura |
|
2009 |
286 |
1 |
p. 134-139 6 p. |
artikel |
5 |
Control of hepatocellular carcinoma through Hepatitis B vaccination in areas of high endemicity: Perspectives for global liver cancer prevention
|
Plymoth, Amelie |
|
2009 |
286 |
1 |
p. 15-21 7 p. |
artikel |
6 |
Editorial Board
|
|
|
2009 |
286 |
1 |
p. ii- 1 p. |
artikel |
7 |
Editorial foreword special issue “Hepatocellular Carcinoma – A Worldwide Translational Approach”
|
Plymoth, Amelie |
|
2009 |
286 |
1 |
p. 3-4 2 p. |
artikel |
8 |
Epidemiology and prevention of hepatocellular carcinoma
|
Franceschi, Silvia |
|
2009 |
286 |
1 |
p. 5-8 4 p. |
artikel |
9 |
Hepatic iron overload and hepatocellular carcinoma
|
Kew, Michael C. |
|
2009 |
286 |
1 |
p. 38-43 6 p. |
artikel |
10 |
Hepatitis B virus induced hepatocellular carcinoma
|
Chemin, I. |
|
2009 |
286 |
1 |
p. 52-59 8 p. |
artikel |
11 |
Hepatitis B virus X gene is implicated in liver carcinogenesis
|
Koike, Katsuro |
|
2009 |
286 |
1 |
p. 60-68 9 p. |
artikel |
12 |
Human hepatocellular carcinoma: Expression profiles-based molecular interpretations and clinical applications
|
Hui, Kam M. |
|
2009 |
286 |
1 |
p. 96-102 7 p. |
artikel |
13 |
Innovative therapy for hepatocellular carcinoma: Three-dimensional high-dose photon radiotherapy
|
Merle, P. |
|
2009 |
286 |
1 |
p. 129-133 5 p. |
artikel |
14 |
Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV infection
|
Chuang, Shu-Chun |
|
2009 |
286 |
1 |
p. 9-14 6 p. |
artikel |
15 |
Molecular pathogenesis and early detection of hepatocellular carcinoma – Perspectives from West Africa
|
Mendy, Maimuna |
|
2009 |
286 |
1 |
p. 44-51 8 p. |
artikel |
16 |
Novel treatments for hepatocellular cancer
|
Kerr, S.H. |
|
2009 |
286 |
1 |
p. 114-120 7 p. |
artikel |
17 |
Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease
|
Feitelson, Mark A. |
|
2009 |
286 |
1 |
p. 69-79 11 p. |
artikel |
18 |
Senescence and immortality in hepatocellular carcinoma
|
Ozturk, Mehmet |
|
2009 |
286 |
1 |
p. 103-113 11 p. |
artikel |
19 |
Systematic -omics analysis of HBV-associated liver diseases
|
Sun, Wei |
|
2009 |
286 |
1 |
p. 89-95 7 p. |
artikel |
20 |
The aflatoxin-induced TP53 mutation at codon 249 (R249S): Biomarker of exposure, early detection and target for therapy
|
Gouas, Doriane |
|
2009 |
286 |
1 |
p. 29-37 9 p. |
artikel |
21 |
The disease relevance of human hepatocellular xenograft models: Molecular characterization and review of the literature
|
Kashofer, K. |
|
2009 |
286 |
1 |
p. 121-128 8 p. |
artikel |
22 |
Worldwide genetic diversity of HBV genotypes and risk of hepatocellular carcinoma
|
Pujol, Flor Helene |
|
2009 |
286 |
1 |
p. 80-88 9 p. |
artikel |